THE problem of systemic arterial embolism in rheumatic heart disease does not end after the patient has survived the acute episode. As protection from re-embolism, which threatens in some 45 per cent ...

Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...

A new device designed to close the left atrial appendage (LAA) and prevent strokes in patients with atrial fibrillation (A-fib) demonstrates a high rate of successful closure with minimal access ...

Please provide your email address to receive an email when new articles are posted on . After successful percutaneous left atrial appendage ligation with the Lariat device, incomplete closure of the ...

Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...

The left atrial appendage (LAA), a site of predilection for thrombus formation, is the primary source of thromboemboli in patients with nonvalvular atrial fibrillation (NVAF) who have a stroke ...

Atrial fibrillation (AF) is a major risk factor for disabling ischemic strokes. Anticoagulation is highly effective for stroke prevention in patients with AF, but a substantial number of patients are ...